Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.45 |
| ▸ | MEN1 | O00255 | 6/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19202306 | 0.90 | PDK2 (0.41) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL26227476 | 0.83 | MEN1 (0.46) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL12745129 | 0.83 | MEN1 (0.49) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL283063 | 0.82 | MAPT (0.55) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL30564983 | 0.82 | MAPT (0.55) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL20871520 | 0.82 | MAPT (0.49) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL15866664 | 0.80 | MAPT (0.57) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL24883319 | 0.80 | MEN1 (0.46) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL1644706 | 0.79 | ALDH1A1 (0.58) | KMT2AMEN1MAPTLMNAKDM4E | |
| SCHEMBL30714362 | 0.79 | MEN1 (0.42) | KMT2AMEN1MAPTLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECH CO LTD (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-4101841-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | TRDMT1, TCF4, TRMT1 | KMT2A 579/4885MEN1 3248/4885MAPT 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.